NAD+ Optimization Beyond NMN: CD38 Inhibition and the Methylation Cycle

The NAD+ Drain Problem

Most biohackers focus on one side of the NAD+ equation: supply. Take NMN or NR, raise NAD+ levels. This is rational but incomplete. NAD+ levels in ageing tissues decline because of two concurrent problems: reduced synthesis and dramatically accelerated degradation.

The primary culprit on the degradation side is an enzyme most longevity practitioners rarely discuss: CD38.

CD38: The NAD+ Destroyer

CD38 is a transmembrane glycoprotein with NAD+ glycohydrolase activity — it cleaves NAD+ into nicotinamide and ADP-ribose. In young, healthy tissue, CD38 plays roles in calcium signalling and immune function. But with age and chronic inflammation, CD38 expression in tissues increases 2–5 fold. ^[]

The consequence is dramatic. A 2016 Cell Metabolism study demonstrated that CD38 is the dominant NAD+-consuming enzyme in ageing tissues — responsible for the progressive NAD+ depletion seen with age, more so than reduced synthetic capacity. Critically, CD38 is preferentially expressed in senescent cells and activated macrophages — explaining why chronic inflammation accelerates NAD+ decline.

Simply supplementing NMN while CD38 remains elevated is like filling a leaky bucket without plugging the hole.

CD38 Inhibitors: Evidence-Based Options

Apigenin (plant flavonoid, found in parsley, chamomile): The most studied natural CD38 inhibitor. A 2013 study showed apigenin treatment in mice significantly increased NAD+ levels in multiple tissues and improved mitochondrial function — outcomes attributable to CD38 inhibition rather than increased synthesis. ^[] Typical dose: 50–100mg/day.

Quercetin (flavonol in onions, capers, red wine): Also inhibits CD38, with additional senolytic properties when combined with dasatinib. Typical dose: 500mg/day.

Luteolin: Another flavonoid CD38 inhibitor with CNS anti-inflammatory properties.

Kuromanin (cyanidin-3-glucoside): Anthocyanin found in dark berries with potent CD38 inhibition in vitro.

The practical stack: apigenin 50mg + quercetin 500mg, taken together with NMN in the morning.

The Methylation Drain

A critical and underappreciated consequence of NMN supplementation: methyl group depletion. NAD+ biosynthesis via the NAM salvage pathway generates nicotinamide, which is methylated by NNMT to 1-methylnicotinamide (MeNAM) — a process that consumes S-adenosylmethionine (SAM), the universal methyl donor. ^[]

With high-dose NMN supplementation, this drain on SAM and methyl groups can deplete methylation capacity needed for:

• DNA methylation (epigenetic regulation)
• Neurotransmitter synthesis (dopamine, serotonin, adrenaline)
• Homocysteine clearance
• Creatine synthesis

TMG (trimethylglycine/betaine) is the solution. As a methyl donor, TMG donates methyl groups to restore SAM, counteracting the methylation drain from NMN use. The empirical ratio: 500mg TMG per 500mg NMN. Long-term NMN users who omit TMG may experience elevated homocysteine, mood changes, or reduced methylation capacity over time.

NNMT Inhibition: The Third Lever

5-Amino-1MQ inhibits NNMT — the enzyme that methylates and degrades NAM. By blocking this degradation pathway, 5-Amino-1MQ spares NAM for NAD+ synthesis. This creates a third, complementary mechanism:

• NMN/NR: increase NAD+ precursor input (synthesis side)
• CD38 inhibitors: reduce NAD+ destruction (degradation side)
• 5-Amino-1MQ: reduce NAM degradation (precursor conservation)

The complete stack addresses NAD+ from all three angles simultaneously.

The Complete NAD+ Optimisation Protocol

| Component | Dose | Mechanism | |-----------|------|-----------| | NMN | 500mg/day | NAD+ precursor input | | TMG | 500mg/day | Methylation support | | Apigenin | 50mg/day | CD38 inhibition | | Quercetin | 500mg/day | CD38 inhibition + senolytic | | 5-Amino-1MQ | 100mg/day (cycles) | NNMT inhibition | | Resveratrol | 500mg/day | SIRT1 activation (uses NAD+) |

The combination creates a NAD+ ecosystem — raising levels via multiple complementary mechanisms while ensuring the metabolic context to use elevated NAD+ effectively.